MXPA04008220A - Ambroxol para tratamiento de estados dolorosos en cavidad bucal y faringea. - Google Patents

Ambroxol para tratamiento de estados dolorosos en cavidad bucal y faringea.

Info

Publication number
MXPA04008220A
MXPA04008220A MXPA04008220A MXPA04008220A MXPA04008220A MX PA04008220 A MXPA04008220 A MX PA04008220A MX PA04008220 A MXPA04008220 A MX PA04008220A MX PA04008220 A MXPA04008220 A MX PA04008220A MX PA04008220 A MXPA04008220 A MX PA04008220A
Authority
MX
Mexico
Prior art keywords
pharyngeal
ambroxol
oral
pharmaceutical composition
pains
Prior art date
Application number
MXPA04008220A
Other languages
English (en)
Spanish (es)
Inventor
Pschorn Uwe
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27740434&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MXPA04008220(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of MXPA04008220A publication Critical patent/MXPA04008220A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Neurosurgery (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MXPA04008220A 2002-02-27 2003-02-25 Ambroxol para tratamiento de estados dolorosos en cavidad bucal y faringea. MXPA04008220A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10208313A DE10208313A1 (de) 2002-02-27 2002-02-27 Ambroxol für die Behandlung von schmerzhaften Zuständen im Mund und Rachenraum
PCT/EP2003/001886 WO2003072094A1 (de) 2002-02-27 2003-02-25 Ambroxol für die behandlung von schmerzhaften zuständen im mund und rachenraum

Publications (1)

Publication Number Publication Date
MXPA04008220A true MXPA04008220A (es) 2004-11-26

Family

ID=27740434

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04008220A MXPA04008220A (es) 2002-02-27 2003-02-25 Ambroxol para tratamiento de estados dolorosos en cavidad bucal y faringea.

Country Status (21)

Country Link
EP (1) EP1480626A1 (ru)
JP (1) JP2005518435A (ru)
KR (1) KR20040084944A (ru)
CN (1) CN1638749A (ru)
AR (1) AR038698A1 (ru)
AU (1) AU2003210345B2 (ru)
BR (1) BR0308038A (ru)
CA (1) CA2477105A1 (ru)
DE (1) DE10208313A1 (ru)
EC (1) ECSP045242A (ru)
IS (1) IS7417A (ru)
MX (1) MXPA04008220A (ru)
MY (1) MY144781A (ru)
PE (1) PE20030830A1 (ru)
PL (1) PL371584A1 (ru)
RU (1) RU2311176C2 (ru)
TW (1) TW200306804A (ru)
UA (1) UA86741C2 (ru)
UY (1) UY27679A1 (ru)
WO (1) WO2003072094A1 (ru)
ZA (1) ZA200405635B (ru)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10332486A1 (de) * 2003-07-16 2005-02-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol für die Behandlung akuter Schmerzen
JP2005120063A (ja) * 2003-10-14 2005-05-12 Boehringer Ingelheim Pharma Gmbh & Co Kg 咽頭における炎症の治療のためのアンブロキソール
ITMI20032462A1 (it) * 2003-12-16 2005-06-17 Advance Holdings Ltd Metodo per preparare una caramella contenente ambroxolo e la caramella cosi' ottenuta
DE102004021992A1 (de) * 2004-05-03 2005-11-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Topische Zubereitung enthaltend Ambroxol
JP2007084471A (ja) * 2005-09-21 2007-04-05 Sunstar Inc 口腔用組成物および口腔用製品の選択方法
EP2015761A4 (en) * 2006-03-29 2009-07-29 Naveh Pharma 1996 Ltd METHODS AND COMPOSITION FOR THE TREATMENT OF THROAT SORE
JP5765934B2 (ja) * 2009-12-28 2015-08-19 サンスター株式会社 口腔用組成物
JP6171683B2 (ja) * 2012-08-03 2017-08-02 大正製薬株式会社 固形製剤
CN105769908B (zh) * 2016-05-06 2019-03-01 湖北凤凰白云山药业有限公司 一种化痰止咳的药物及其制备方法
CN109982692A (zh) 2016-11-14 2019-07-05 王明武 用于治疗眼表疾病的制剂和相关方法
CN106727621A (zh) * 2016-11-22 2017-05-31 郑州仁宏医药科技有限公司 一种治疗牙痛的西药散剂
JP6844394B2 (ja) * 2017-04-14 2021-03-17 大正製薬株式会社 固形組成物
EP3415143A1 (en) 2017-06-16 2018-12-19 Kai-Uwe Kern Bromhexine for the treatment of pain

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3432411A1 (de) * 1983-09-17 1985-04-11 Dr. Karl Thomae Gmbh, 7950 Biberach Antiadhaesive prohylactica und arzneimittel, enthaltend ein sekretolytisch wirksames benzylaminderivat
DE3445226A1 (de) * 1983-12-14 1985-08-01 Reifenrath, Rainer Richard Otto, Dr.med., 7920 Heidenheim Pharmazeutisches erzeugnis zur behandlung und prophylaxe von infektionen sowie von husten und obstruktiven atemwegserkrankungen
US5122540A (en) * 1986-02-28 1992-06-16 W. Keith R. Watson Method and composition for treating warts and throat soreness with DMSO and citric acid
DE4415553A1 (de) * 1994-05-03 1995-11-09 Behringwerke Ag Verwendung von Deoxyspergualin zur Herstellung eines Arzneimittels zur Behandlung von entzündlich-hyperreaktiven Erkrankungen
US6231890B1 (en) * 1996-05-02 2001-05-15 Taisho Pharmaceutical Co., Ltd. Suspension of sparingly water-soluble acidic drug
DE19933148A1 (de) * 1999-07-20 2001-01-25 Boehringer Ingelheim Int Ambroxolhaltige Lutschtablette
JP2001151677A (ja) * 1999-11-26 2001-06-05 Taisho Pharmaceut Co Ltd 咽頭用組成物
DE20102817U1 (de) * 2000-02-23 2001-06-07 Bolder Arzneimittel GmbH, 50968 Köln Lutsch- und Kaupastillen mit Cyclodextrin
US6391886B1 (en) * 2000-12-04 2002-05-21 The Procter & Gamble Company Oral compositions having improved consumer aesthetics

Also Published As

Publication number Publication date
ECSP045242A (es) 2004-09-28
AR038698A1 (es) 2005-01-26
RU2004129284A (ru) 2005-06-10
WO2003072094A1 (de) 2003-09-04
DE10208313A1 (de) 2003-09-11
JP2005518435A (ja) 2005-06-23
MY144781A (en) 2011-11-15
EP1480626A1 (de) 2004-12-01
UA86741C2 (ru) 2009-05-25
AU2003210345B2 (en) 2009-01-29
UY27679A1 (es) 2003-09-30
IS7417A (is) 2004-08-19
RU2311176C2 (ru) 2007-11-27
AU2003210345A1 (en) 2003-09-09
KR20040084944A (ko) 2004-10-06
PE20030830A1 (es) 2003-10-31
CN1638749A (zh) 2005-07-13
CA2477105A1 (en) 2003-09-04
PL371584A1 (en) 2005-06-27
TW200306804A (en) 2003-12-01
ZA200405635B (en) 2005-05-31
BR0308038A (pt) 2004-12-28

Similar Documents

Publication Publication Date Title
US10493068B2 (en) Pharmaceutical compositions comprising a local anaesthetic such as bupivacaine for local administration to the mouth or throat
US5614207A (en) Dry mouth lozenge
US6406717B2 (en) Rapid-melt semi-solid compositions, methods of making same and methods of using same
US9161909B2 (en) Adhesive compositions for the treatment of xerostomia
US20090263467A1 (en) Combination drug therapy using orally dissolving film or orally disintegrating tablet dosage forms to treat dry mouth ailments
Collins et al. Bioadhesive lozenge for the improved delivery of cetylpyridinium chloride
EP1965787B1 (en) Treatment of xerostomia with a sulfur-containing antioxidant
JP2012513955A (ja) 経口投与剤形
US20100330176A1 (en) Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity
CZ289643B6 (cs) Lék pro léčbu bolesti v krku obsahující flurbiprofen
MXPA04008220A (es) Ambroxol para tratamiento de estados dolorosos en cavidad bucal y faringea.
JP2022132446A (ja) 低中毒性抗コリン作動性エステルのための方法および組成物
EP2027852A1 (en) Adhesive compositions for the treatment of xerostoma
ZA200308664B (en) Solid orally-dispersible pharmaceutical formulation.
EP2892528B1 (en) Pharmaceutical compositions comprising flurbiprofen
Khatiwara et al. An emerging technique of medicated chewing gum in drug delivery system: a review
JP2000063268A (ja) 口腔粘膜付着型徐放性錠剤及び歯周疾患治療剤
JP6315741B2 (ja) ＮＳＡＩＤｓまたはヘパリン類含有口腔用組成物
JP2015178462A (ja) イブプロフェンの口腔内濯ぎ剤

Legal Events

Date Code Title Description
FA Abandonment or withdrawal